Prof. Patricia A. Kruk

University of South Florida, USA

Email: [email protected]

Qualifications

1992 Ph.D., University of British Columbia, Medical Sciences

1983 M.Sc., University of Alberta, Zoology

1980 B.Sc., Concordia University, Biological Sciences

Publications (selected)

1. Zhang, Y., Zhang, M., Dong, H., et al. (2024). Editorial Expression of Concern: Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene, 43(32), 2491.
2. Yang, H., He, L. L., Kruk, P., et al. (2019). Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells (Expression of Concern of Vol 119, Pg 2304, 2006). International Journal of Cancer, 144(11), E8.
3. Buttermore, S. T., Hoffman, MS., Kumar, A., et al. (2017). Increased RHAMM expression relates to ovarian cancer progression. Journal of Ovarian Research, 10, Article 66.
4. Xu, C. X., Xu, M., Tan, L., et al. (2016). MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog (vol 287, pg 34970, 2012). Journal of Biological Chemistry, 291(43), 22851.
5. Buttermore, S., & Kruk, P. (2016). Hyaluronan-mediated motility receptor (RHAMM) in ovarian cancer. Cancer Research, 76(Suppl 14), Abstract 444.
6. Mohamed, M., & Kruk, P. (2016). Amylase overexpression promotes ovarian cancer invasion. Cancer Research, 76(Suppl 14), Abstract 5080.
7. Woolery, K. T., Mohamed, M., Linger, R. J., et al. (2015). BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells. Biomed Research International, 2015, Article 652017.
8. Woolery, K. T., Hoffman, M. S., Kraft, J., et al. (2014). Urinary interleukin-1β levels among gynecological patients. Journal of Ovarian Research, 7, Article 104.
9. Kasiappan, R., Shen, Z., Tse, A. K. W., et al. (2012). 1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498. Journal of Biological Chemistry, 287(49), 41297–41309.
10. Xu, C. X., Xu, M., Tan, L., et al. (2012). RETRACTED: MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog (Retracted Article). Journal of Biological Chemistry, 287(42), 34970–34978.
11. Onen, O., Sisman, A., Gallant, N. D., et al. (2012). A Urinary Bcl-2 Surface Acoustic Wave Biosensor for Early Ovarian Cancer Detection. Sensors, 12(6), 7423–7437.
12. Esposito, N. N., Kruk, P. A., Hoffman, M., et al. (2011). Intraoperative harvesting of human fallopian tubes for cytodiagnostic and pathobiological studies. Cancer Research, 71(Suppl 8), Abstract 2226.
13. Woolery, K. T., Linger, R. J., & Kruk, P. A. (2011). A novel role for the 185delAG BRCA1 mutant protein, BRAT, in ovarian cancer pathology. Cancer Research, 71(Suppl 8), Abstract 2030.
14. Linger, R. J., & Kruk, P. A. (2010). BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications. FEBS Journal, 277(15), 3086–3096.
15. Anderson, N. S., Rojiani, M., & Kruk, P. A. (2010). Lysophosphatidic acid upregulates Bcl-2 production and secretion in ovarian cancer cells. Cancer Research, 70(Suppl 8), Abstract 1037.
16. Drenberg, C. D., Bermudez, Y., Nicosia, S. V., et al. (2010). Semaphorin 3F suppresses telomerase activity. Cancer Research, 70(Suppl 8), Abstract 3208.
17. Drenberg, C. D., Saunders, B. O., Wilbanks, G. D., et al. (2010). Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer. Gynecologic Oncology, 117(1), 117–124.
18. Linger, R. J., & Kruk, P. A. (2010). A novel role for the 185delAG BRCA1 mutant protein, BRAT, in ovarian cancer pathology. Cancer Research, 70(Suppl 8), Abstract 1852.
19. Esposito, N. N., Kruk, P. A., Shutter, J., et al. (2010). Intraoperative Cytology of Fallopian Tube. Laboratory Investigation, 90(Suppl 1), 241A.
20. Esposito, N. N., Kruk, P. A., Shutter, J., et al. (2010). Intraoperative Cytology of Fallopian Tube. Modern Pathology, 23(Suppl 1), 241A.